Stock Under $10 with 50-100% upside potential - 14 Days FREE!

WebMD Highlights Top Health Stories Of 2012

Stock quotes in this article: WBMD 

NEW YORK, Dec. 5, 2012 /PRNewswire/ -- WebMD Health Corp. (NASDAQ: WBMD), the leading source of health information, today released its 2012 Year in Health, an annual listing of the most popular health topics of the year for consumers and physicians. Although health care reform topped the consumer 2012 list, the topics varied from healthy living, including health management, to deadly diseases. For physicians, Medicare was a leading topic, with new screening guidelines and new drug approvals making the 2012 list.

"Certain news stories clearly resonate with consumers and physicians and proliferate across all media channels. This year, a Supreme Court ruling and presidential election focused the spotlight on health care reform," said Michael Smith, MD, WebMD's Chief Medical Editor. "Both consumers and physicians turned to WebMD and Medscape to better understand how the changing health care system may affect them."

WebMD uniquely understands consumer and physician search and sharing behaviors across mobile and desktop. Mobile devices empower and enable consumers and physicians to make important health decisions anytime, anywhere through our multiscreen platform.

WebMD's Top 10 Stories of the Year :

1.   Health Care Reform Under Fire

2.  Deadly Diseases

3.  New Weight Loss Drugs

4.  Do Men Need a PSA Test?

5.  Fungal Meningitis Outbreak

6.  Are We Sitting Our Lives Away?

7.   Where's My Excedrin?

8.   The Dangers of Designer Drugs

9.   Children Developing (Adult) Chronic Conditions

10.   Food and Drink Villains

Medscape Top 10 Stories of the Year :

1.  Supreme Court Upholds Health Care Reform

2.  Are Physicians Coding Too Many 99214s?

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,345.03 37.86 0.25%
NASDAQ 3,456.81 -6.49 -0.19%
S&P 500 1,649.56 -5.79 -0.35%
US 10 Yr 2.019% -0.007

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs